Literature DB >> 22513259

Optimization of un-tethered, low voltage, 20-100kHz flexural transducers for biomedical ultrasonics applications.

Youhan Sunny1, Christopher R Bawiec, An T Nguyen, Joshua A Samuels, Michael S Weingarten, Leonid A Zubkov, Peter A Lewin.   

Abstract

This paper describes optimization of un-tethered, low voltage, 20-100kHz flexural transducers for biomedical ultrasonics applications. The goal of this work was to design a fully wearable, low weight (<100g), battery operated, piezoelectric ultrasound applicator providing maximum output pressure amplitude at the minimum excitation voltage. Such implementation of ultrasound applicators that can operate at the excitation voltages on the order of only 10-25V is needed in view of the emerging evidence that spatial-peak temporal-peak ultrasound intensity (I(SPTP)) on the order of 100mW/cm(2) delivered at frequencies below 100kHz can have beneficial therapeutic effects. The beneficial therapeutic applications include wound management of chronic ulcers and non-invasive transdermal delivery of insulin and liposome encapsulated drugs. The early prototypes of the 20 and 100kHz applicators were optimized using the maximum electrical power transfer theorem, which required a punctilious analysis of the complex impedance of the piezoelectric disks mounted in appropriately shaped metal housings. In the implementation tested, the optimized ultrasound transducer applicators were driven by portable, customized electronics, which controlled the excitation voltage amplitude and facilitated operation in continuous wave (CW) or pulsed mode with adjustable (10-90%) duty cycle. The driver unit was powered by remotely located rechargeable lithium (Li) polymer batteries. This was done to further minimize the weight of the applicator unit making it wearable. With DC voltage of approximately 15V the prototypes were capable of delivering pressure amplitudes of about 55kPa or 100mW/cm(2) (I(SPTP)). This level of acoustic output was chosen as it is considered safe and side effects free, even at prolonged exposure.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22513259      PMCID: PMC3392430          DOI: 10.1016/j.ultras.2012.03.004

Source DB:  PubMed          Journal:  Ultrasonics        ISSN: 0041-624X            Impact factor:   2.890


  6 in total

1.  Transdermal drug delivery using low-frequency sonophoresis.

Authors:  S Mitragotri; D Blankschtein; R Langer
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

2.  Low-dose ultrasound effects on wound healing: a controlled study with Yucatan pigs.

Authors:  N N Byl; A L McKenzie; J M West; J D Whitney; T K Hunt; H A Scheuenstuhl
Journal:  Arch Phys Med Rehabil       Date:  1992-07       Impact factor: 3.966

Review 3.  Liposomes in ultrasonic drug and gene delivery.

Authors:  Shao-Ling Huang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

4.  Mass transport enhancement by ultrasound in non-degradable polymeric controlled release systems.

Authors:  I Lavon; J Kost
Journal:  J Control Release       Date:  1998-06       Impact factor: 9.776

5.  The effect of noncontact, low-intensity, low-frequency therapeutic ultrasound on lower-extremity chronic wound pain: a retrospective chart review.

Authors:  Marie L Gehling; John H Samies
Journal:  Ostomy Wound Manage       Date:  2007-03       Impact factor: 2.629

6.  Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer.

Authors:  E J Park; Jacob Werner; Nadine Barrie Smith
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.580

  6 in total
  9 in total

1.  Applicability and safety of dual-frequency ultrasonic treatment for the transdermal delivery of drugs.

Authors:  Carl M Schoellhammer; Sharanya Srinivasan; Ross Barman; Stacy H Mo; Baris E Polat; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2015-02-04       Impact factor: 9.776

Review 2.  Skin permeabilization for transdermal drug delivery: recent advances and future prospects.

Authors:  Carl M Schoellhammer; Daniel Blankschtein; Robert Langer
Journal:  Expert Opin Drug Deliv       Date:  2014-01-07       Impact factor: 6.648

3.  Enhanced therapeutic anti-inflammatory effect of betamethasone on topical administration with low-frequency, low-intensity (20 kHz, 100 mW/cm(2)) ultrasound exposure on carrageenan-induced arthritis in a mouse model.

Authors:  Gadi Cohen; Hiba Natsheh; Youhan Sunny; Christopher R Bawiec; Elka Touitou; Melissa A Lerman; Philip Lazarovici; Peter A Lewin
Journal:  Ultrasound Med Biol       Date:  2015-05-21       Impact factor: 2.998

4.  Effects of Non-thermal, Non-cavitational Ultrasound Exposure on Human Diabetic Ulcer Healing and Inflammatory Gene Expression in a Pilot Study.

Authors:  Anamika Bajpai; Sumati Nadkarni; Michael Neidrauer; Michael S Weingarten; Peter A Lewin; Kara L Spiller
Journal:  Ultrasound Med Biol       Date:  2018-06-22       Impact factor: 2.998

5.  Finite element static displacement optimization of 20-100 kHz flexural transducers for fully portable ultrasound applicator.

Authors:  Christopher R Bawiec; Youhan Sunny; An T Nguyen; Joshua A Samuels; Michael S Weingarten; Leonid A Zubkov; Peter A Lewin
Journal:  Ultrasonics       Date:  2012-09-14       Impact factor: 2.890

6.  Low-frequency (<100 kHz), low-intensity (<100 mW/cm(2)) ultrasound to treat venous ulcers: a human study and in vitro experiments.

Authors:  Joshua A Samuels; Michael S Weingarten; David J Margolis; Leonid Zubkov; Youhan Sunny; Christopher R Bawiec; Dolores Conover; Peter A Lewin
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

Review 7.  Ultrasound-enhanced transdermal delivery: recent advances and future challenges.

Authors:  Matthias A Oberli; Carl M Schoellhammer; Robert Langer; Daniel Blankschtein
Journal:  Ther Deliv       Date:  2014-07

8.  Torsional Ultrasound Sensor Optimization for Soft Tissue Characterization.

Authors:  Juan Melchor; Rafael Muñoz; Guillermo Rus
Journal:  Sensors (Basel)       Date:  2017-06-15       Impact factor: 3.576

Review 9.  Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity.

Authors:  Celina Amaya; Elizabeth R Smith; Xiang-Xi Xu
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.